“This unique structure with Med-X is an opportunity for me to continue to grow my business through the implementation of the highly effective Nature-Cide line of products and to be part of the growing movement to use environmentally safe products,” states Roger Meints, founder and owner of Akamai, in a press release.
Signing this LOI is a key milestone for Med-X, explains its president and COO, Matthew Mills, in a press release: “This acquisition unveils another step in the growth of our Nature-Cide division branding model via strategic acquisitions and/or partnerships. We are striving to create new opportunities for environmentally conscious pest control and product companies as an alternative to traditional acquisitions offered by other top pest control companies. In fact, we firmly believe that the Med-X acquisition/partnership opportunity can create greater growth and financial upside for the right small business owner and natural products developers who want to continue to work and grow their business alongside Med-X and our assortment of brands and divisions.”
The closing of the acquisition is subject to several conditions, including without limitation, satisfactory completion of a due diligence investigation and execution of a definitive purchase agreement. Upon a successful closing, Akamai Pest Solutions will become a wholly owned subsidiary of Med-X, operating as part of the Nature-Cide Service division.
Nature-Cide provides commercial and residential customers with all-natural, “green” products for controlling insects and repelling rodents, reptiles and various birds.